News
The stock's rise snapped a four-day losing streak.
In a report released yesterday, Caitlin Cronin from Canaccord Genuity reiterated a Buy rating on TELA Bio (TELA – Research Report), with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback